Gregory Mark Weinhoff
Director of Finance/CFO chez CENTESSA PHARMACEUTICALS PLC
Fortune : 3 M $ au 31/03/2024
Profil
Gregory Mark Weinhoff is the founder of Ella Health, Inc. (founded in 2011) and Arvelle Therapeutics International GmbH (founded in 2019).
He holds the title of Director at Ella Health, Inc. and Chief Financial & Business Officer, Director at Arvelle Therapeutics International GmbH.
He was also the founder of Arvelle Therapeutics BV (founded in 2019) and held the title of Chief Financial & Business Officer at the company from 2019 to 2021.
Dr. Weinhoff's current job(s) include being a Venture Partner at Healthinvest Equity Partners and Chief Financial & Accounting Officer at Centessa Pharmaceuticals Plc.
His former job(s) include being the Chief Executive Officer & Director at Amicus Therapeutics, Inc. from 2002 to 2009, Executive Chairman at Resolvyx Pharmaceuticals, Inc., Director at LuMend, Inc., Director at Concerto Health Services, Inc., Director at PrimeraDx, Inc., Director at Celula, Inc., Director at VaxInnate Corp., Senior Associate at J.H.
Whitney Capital Partners, LLC from 2000 to 2001, Financial Analyst at Morgan Stanley & Co. LLC, Senior Associate at W.G.
Shaheen & Associates Ltd., Chief Financial & Accounting Officer at Sio Gene Therapies, Inc. from 2018 to 2019, Chief Financial Officer at Axovant Sciences, Inc. from 2015 to 2019, and Vice President & Partner at CHL Healthcare Partners LLC from 2012 to 2013.
Dr. Weinhoff's education history includes a doctorate degree from Harvard Medical School, an MBA degree from Harvard Business School, and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 265 111 ( 0,29% ) | 3 M $ | 31/03/2024 |
Postes actifs de Gregory Mark Weinhoff
| Sociétés | Poste | Début |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Director of Finance/CFO | 01/03/2021 |
Healthinvest Equity Partners
 Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | Private Equity Investor | - |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Founder | 01/01/2019 |
Anciens postes connus de Gregory Mark Weinhoff
| Sociétés | Poste | Fin |
|---|---|---|
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Founder | 01/02/2021 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Director of Finance/CFO | 30/06/2019 |
| SIO GENE THERAPIES INC. | Director of Finance/CFO | 30/06/2019 |
| AMICUS THERAPEUTICS, INC. | Chief Executive Officer | 07/01/2009 |
J.H. Whitney Capital Partners, LLC
 J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | Corporate Officer/Principal | 01/01/2001 |
Formation de Gregory Mark Weinhoff
| Harvard Medical School | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 16 |
|---|---|
LuMend, Inc.
 LuMend, Inc. Medical SpecialtiesHealth Technology LuMend, Inc. used to develop medical devices. It delivered technology and services to interventional cardiologists, radiologists and vascular surgeons specializing in endovascular techniques for the treatment of peripheral vascular diseases. The company also provided a clinical solution to chronic total occlusions. LuMend was founded by John B. Simpson & Matthew R. Selmon in 1996 and was headquartered in Redwood City, CA. | Health Technology |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | Finance |
Concerto Health Services, Inc.
 Concerto Health Services, Inc. Medical/Nursing ServicesHealth Services Concerto Health Services, Inc. provides healthcare services. It offers clinical care and care coordination services to dual-eligible beneficiaries. The company was founded by Samuel R. Willcoxon and David L. Steffy in 2004 and is headquartered in Schaumburg, IL. | Health Services |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Health Technology |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Ella Health, Inc.
 Ella Health, Inc. Medical/Nursing ServicesHealth Services Ella Health, Inc. provides breast cancer screening and diagnostic services. Its 3D mammogram focuses on the breast cancer screening, prevention and early detection of diseases that predominantly target women. The company was founded by Joseph B. Hoban and Gregory Mark Weinhoff in 2011 and is headquartered in Lemoyne, PA. | Health Services |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
CHL Healthcare Partners LLC
 CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners LLC (CHL Medical Partners) is a venture capital firm co-founded in 1997 by Jeff Collinson, Tim Howe and Ron Lennox. The firm is headquartered in Fairfield, Connecticut. | Finance |
Celula, Inc.
 Celula, Inc. Medical/Nursing ServicesHealth Services Celula, Inc. provides diagnostic testing services. It develops innovative instruments for clinical diagnostics and biomedical research using advanced micro fluidics and other technologies. The company was founded in May 2005 by Philippe J. Marchand, Andy Katz and Haichuan Zhang and is headquartered in San Diego, CA. | Health Services |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
W.G. Shaheen & Associates Ltd.
 W.G. Shaheen & Associates Ltd. Investment ManagersFinance W.G. Shaheen & Associates Ltd. (do business as Whitney & Co.) is an independent, SEC-registered investment advisor and wealth management firm headquartered in Rochester, New York. The firm was founded in 1975, and offers discretionary portfolio management services to individuals, high net-worth individuals, pension plans/profit sharing plans, and foundations/charities. | Finance |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | Finance |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Health Technology |
Arvelle Therapeutics BV
Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Commercial Services |
